Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

BUY
$40.66 - $53.03 $2.75 Million - $3.58 Million
67,600 New
67,600 $3.15 Million
Q1 2022

May 16, 2022

SELL
$59.95 - $92.06 $24.5 Million - $37.7 Million
-409,230 Closed
0 $0
Q4 2021

Feb 14, 2022

SELL
$81.07 - $121.29 $9.73 Million - $14.6 Million
-120,000 Reduced 22.67%
409,230 $33.2 Million
Q3 2021

Nov 15, 2021

BUY
$101.99 - $166.36 $15.6 Million - $25.4 Million
152,900 Added 40.63%
529,230 $61.6 Million
Q2 2021

Aug 16, 2021

BUY
$141.6 - $179.06 $53.3 Million - $67.4 Million
376,330 New
376,330 $62.4 Million
Q1 2021

May 17, 2021

SELL
$132.81 - $182.18 $20.7 Million - $28.4 Million
-156,046 Closed
0 $0
Q4 2020

Feb 16, 2021

SELL
$138.17 - $184.34 $79.4 Million - $106 Million
-574,931 Reduced 78.65%
156,046 $27 Million
Q3 2020

Nov 16, 2020

SELL
$114.09 - $145.51 $36.9 Million - $47 Million
-323,126 Reduced 30.65%
730,977 $102 Million
Q2 2020

Aug 14, 2020

SELL
$89.45 - $129.85 $62.5 Million - $90.7 Million
-698,517 Reduced 39.86%
1,054,103 $126 Million
Q1 2020

May 15, 2020

BUY
$70.23 - $144.31 $40.9 Million - $84.1 Million
582,540 Added 49.79%
1,752,620 $175 Million
Q4 2019

Feb 14, 2020

BUY
$76.41 - $117.54 $16.5 Million - $25.4 Million
216,260 Added 22.67%
1,170,080 $138 Million
Q3 2019

Nov 14, 2019

SELL
$61.52 - $91.1 $16.9 Million - $25 Million
-273,910 Reduced 22.31%
953,820 $82 Million
Q2 2019

Aug 14, 2019

BUY
$58.04 - $66.99 $56.3 Million - $65 Million
970,740 Added 377.73%
1,227,730 $79.6 Million
Q1 2019

May 15, 2019

BUY
$35.52 - $62.62 $3.61 Million - $6.36 Million
101,580 Added 65.36%
256,990 $16.1 Million
Q4 2018

Feb 14, 2019

BUY
$35.43 - $56.29 $5.51 Million - $8.75 Million
155,410 New
155,410 $6.04 Million

Others Institutions Holding NVRO

About NEVRO CORP


  • Ticker NVRO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 35,387,800
  • Market Cap $173M
  • Description
  • Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It...
More about NVRO
Track This Portfolio

Track Health Cor Management, L.P. Portfolio

Follow Health Cor Management, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Health Cor Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Health Cor Management, L.P. with notifications on news.